- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 06.01. | Novo Nordisk asks FDA not to allow GLP-1 compounding | ||
| 03.01. | Patient organisations 'too influenced by corporate funders' | ||
| 03.01. | London-listed Poolbeg discussing Hookipa merger | ||
| 03.01. | CARsgen gets a win for CAR-T in solid tumours | ||
| 03.01. | Regeneron builds in eye disease tech with Oxular takeover | ||
| 03.01. | Capricor files cell therapy for DMD cardiomyopathy with FDA | ||
| 02.01. | Neumora laid low by depression trial failure | ||
| 02.01. | Hutchmed cashes in a Chinese JV to help fund its pipeline | ||
| 02.01. | Roche licenses Innovent ADC that could challenge Amgen drug | ||
| 02.01. | Flagship-backed AI startup Valo shelves eye disease drug | ||
| 02.01. | Early cancer diagnoses reach record level in NHS | ||
| 31.12.24 | New data could widen use of Novartis' SMA therapy Zolgensma | ||
| 31.12.24 | Pfizer ducks out of Sangamo haemophilia A alliance | ||
| 30.12.24 | First global approval for Daiichi Sankyo's Dato-DXd | ||
| 30.12.24 | Opdivo's subcutaneous PD-1 inhibitor cleared in US | ||
| 27.12.24 | Amid BIOSECURE Act speculation, WuXi AppTec sells unit | ||
| 27.12.24 | PhRMA said to be donating $1m to Trump inauguration | ||
| 24.12.24 | Daiichi and AZ pull Dato-DXd filing in Europe too | ||
| 24.12.24 | FDA approves flurry of drugs ahead of holiday season | ||
| 24.12.24 | AZ gets EU okay for Tagrisso in early-stage lung cancer | ||
| 24.12.24 | Sanofi takes SK Bio-partnered pneumococcal shot into phase 3 | ||
| 19.12.24 | Novartis sheds MorphoSys staff, sites after pelabresib delay | ||
| 19.12.24 | Vertex weakens after neuropathic pain trial reads out | ||
| 19.12.24 | Neuralink rival Precision raises $102m, and other financings | ||
| 19.12.24 | Roche's Parkinson's hope fails second clinical trial |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
